Staphylococcus aureus or hemolytic Staphylococcus albus were picked, subinoculated on extract agar slants, and then subjected to a preliminary screening by the standard coagulase test with living cultures and by mannite fermentation tests. Only strains positive by these procedures were used for further quantitative studies. The clinical sources were arbitrarily grouped into 6 categories (table 2). The nose and throat strains, obtained, in the main, from the Pediatrics Service, presumably were not producing any clinical effects ascribable to them. The relationship of the staphylococci derived from the ears, eyes, skin, and vagina, as well as those from urine, to the production of clinical disease, is perhaps intermediate, in the sense that at times the organisms were incriminated as the causative organisms, while at other times they were secondary invaders or even played no special pathogenic r6le. The strains assembled under group 6 were most likely directly involved in the production of lesions. In this group are included strains from boils, carbuncles, sepsis, osteomyelitis, staphylococcal endocarditis, infected burns, infected surgical wounds, etc.
The production of coagulase. Difco brain-heart infusion broth was employed, made up to contain 37 gm. per 1000 ml. of distilled water. To this was added a mixture of trace elements, in the amount of 1 The staphylococci were seeded from extract agar slants into tubes of brain-heart broth, incubated for 3 hours at 370C., and 3 ml. lots were subinoculated into 20 to 30 ml. of the same medium in bottles 4 x 4 x 10 cm. in size, and of a capacity of 100 ml. The cultures were then incubated for 5 days at 35 to 37 'C. At this time, the broth was cleared by centrifugation, and merthiolate was added to a final concentration of 1:10,000. No filtration was carried out, but controls established that the coagulase titers represented the content of the supernatant fluid rather than the further elaboration of coagulase by the organisms. Plasmas were seldom used if they required more than a 100 per cent correction.
Produiction of rahbit, sheep, and human red blood cell lysins. The method has been previously described.10 In brief, the toxins were produced in a rapid shake culture for 16 hours, using heart infusion broth. The titration of the toxins was according to well-established procedure.14 The Lh dose of the rabbit cell lysin was determined against an antitoxin prepared from a therapeutic Lederle staphylococcal antitoxin, which, in turn, had been adjusted against the National Institute of Health standard. With each group of unknown strains, a culture of "Wood 46," a good alpha hemolysin-producing organism, was included to serve as a check of the adequacy of the test conditions.
Experimental results
The quantitative production of coagulase. The distribution of coagulase titers among 242 positive strains is given in table 1 . The organisms were classified as "low," "intermediate," and "high" in coagulase production according to the arbitrary division indicated in the table. It will be noted that the majority of the strains exhibit a capacity to elaborate a limited amount of coagulase in vitro, although a small group possesses this property to a high degree. It appeared of particular interest to determine whether the results obtained with the group most intimately associated with the production of clinical disease, group 6, differed significantly from the other sources. Subjecting the data to the chi-square test* it was first found that differences among the first four groups were not valid. Similarly, group 4 did not differ significantly from group 6. When, however, the first two or the first four groups were compared to group 6, the difference was statistically valid, with P giving a value of 0.03.
The question might well be raised as to the validity of the methods used. In the course of observations on many factors influencing coagulase production, it was established that duplicate checks on samples grown in separate bottles may be readily obtained when tests are carried out at the same time, with the same inoculum, and on the same medium. Such differences as may occur usually fall within less than one dilution, and identical results were frequently achieved. It was further desirable to note the constancy of coagulase production by the same strain at different times. Accordingly, 100 strains were selected at random and retested some months later under as nearly identical conditions as possible. That the titers were frequently not the same as previously obtained is not surprising. However, 90 per cent of the organisms showed titers within the same general group of "low," "intermediate," or "high" as on the previous test, while 10 per cent of the strains exhibited greater disparity in the results. It should be pointed out, however, that under prolonged cultivation a strain may undergo profound changes in its capacity to produce coagulase.
The quantitative production of rabbit cell lysin. In all, 235 strains were examined for alpha lysin, and the titers were expressed in terms of the Lh dose of the toxin. The results are summarized in table 3, in which the strains were arbitrarily grouped under the headings of "low," "intermediate," and "high" as indicated. It will be noted that, contrary to the preponderance of low coagulase production, toxin elaboration was equally distributed among the three categories. When the strains derived from the mucous membranes of groups 1, 2, and 3 were set up against group 6 in a chi-square test, no statistically significant difference was evident, with P giving a value of 0.6. Awareness of these clinical guide-posts, in the face of infection not responding satisfactorily to penicillin or to sulfonamide therapy, may prove of far greater service to the physician than the attempts at direct application of quantitatively established coagulase and toxin titers to the appraisal of the clinical picture. Summary 1. The quantitative production of coagulase and of toxins has been studied in an attempt to determine the correlation of these properties with the clinical origin of the staphylococci.
2. Of 242 strains, 66 per cent produced slight amounts of coagulase while 8.7 per cent yielded high titers.
3. More strains derived from the nose, throat, ears, eyes, skin, and vagina had higher coagulase titers than did strains isolated from lesions, and this difference was statistically significant. 4 . No significant differences were found in the quantity of rabbit cell lysin and sheep and human cell lysins among strains derived from different clinical sources.
5. There was no correlation between the quantity of coagulase and of rabbit cell lysin production.
6. The possible clinical implications of the findings are considered.
